Search results
Mankind Shoots its $1.6b Shot, gets BSV - The Economic Times
The Economic Times· 2 days agoHere's the listThe transaction is expected to close within three-four months subject to regulatory...
Mankind Pharma to acquire BSV for ₹13,630 crore
The Hindu· 2 days agoMankind Pharma acquires Bharat Serums and Vaccines, becoming a market leader in women's health and fertility segment.
Mankind Pharma trumps EQT-ADIA, set to acquire BSV for Rs 14,000 crore - ET HealthWorld | Pharma
The Economic Times· 3 days agoMumbai: Mankind Pharma, India’s fourth largest pharma company by market share, is all set to acquire...
Mankind Pharma to acquire 100 percent stake in BSV; Plans to expand high entry barrier portfolio
Financial Express· 2 days agoAccording to the company’s press statement, the deal is of an enterprise value of approx. Rs. 13,630...
Mankind Pharma is frontrunner in Bharat Serums bid
The Economic Times· 3 days agoMankind Pharma Ltd. is emerging as the frontrunner to acquire Bharat Serums & Vaccines Ltd. in a deal that could value the target company at around $1.5...
...Mahindra, DFL, Jupiter Wagons, AU Small Finance Bank, United Breweries, Mankind Pharma, IndusInd...
Financial Express· 2 days agoGIFT Nifty traded up by 7 points or 0.03% at 24,462.50 indicating a lacklustre opening for domestic...
Morning Scan: All the big stories to get you started for the day
CNBC Awaaz· 2 days agoThe Taiwanese contract manufacturer may start assembling iPads at its Sriperumbudur factory in Tamil...
Higher PLI budget to promote specialty drugs and gene therapies
Financial Express· 1 day agoAnticipating higher investments from the pharmaceutical companies, the government has increased the...
Sun Pharma gets USFDA nod for its formulation to treat Severe Alopecia Areata
Financial Express· 2 days agoSun Pharmaceutical Industries Limited on Friday announced that the U.S. Food and Drug Administration...
Cipla To Sun Pharma: gRevlimid To Drive Q1 Sales Growth For Pharma, Say Analysts
NDTV Profit· 4 days agoHere's what brokerages expect for the pharma sector in first quarter of fiscal 2025.